Metastatic colorectal cancer: advances in biochemical modulation and new drug development
Meropol, N.J.; Creaven, P.J.; Petrelli, N.J.
Seminars in Oncology 22(5): 509-524
1995
ISSN/ISBN: 0093-7754 PMID: 7570061 Document Number: 439742
Document emailed within 1 workday
Related Documents
Grem, J.L. 2001: Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer Oncology 15(1 Suppl 2: 13-19Manziuk, L.V.; Perevodchikova, N.I.; Gorbunova, V.A.; Luk'ianchenko, A.B.; Abramova, N.A. 1996: Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer Voprosy Onkologii 42(3): 33-36
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Sugiyama, Y.; Saji, S.; Miya, K.; Fukada, D.; Umemoto, T.; Kunieda, K.; Takao, H.; Kato, M.; Tsuji, K. 1995: A new modality of locoregional chemotherapy based on biochemical double modulation of 5-fluorouracil with both leucovorin and cisplatin against liver metastases of colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1460-1463
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
2009: Panitumumab: new drug. Metastatic colorectal cancer: don't make things worse! Prescrire International 18(102): 157
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Kato, K. 2011: Development of oral drugs in the standard therapy for metastatic colorectal cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 454-458
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Kawasaki, H.; Nobori, T.; Kamiya, H.; Sakurai, M. 1985: Biochemical modulation in cancer chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(4): 815-829
Kovalev, A.A.; Tsvetaeva, D.A.; Grudinskaja, T.V. 2013: Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer Experimental Oncology 35(4): 287-290
Shirasaka, T.; Yamamitsu, S.; Tsuji, A.; Terashima, M.; Hirata, K. 2000: Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(6): 832-845
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Bartlett, D.L.; Chu, E. 2012: Can metastatic colorectal cancer be cured? Oncology 26(3): 266-275
Saltz, L.B. 2014: Management of metastatic colorectal cancer Oncology 28(10): 841
Patanaphan, V.; Salazar, O.M. 1993: Colorectal cancer: metastatic patterns and prognosis Southern Medical Journal 86(1): 38-41
Katsumoto, Y.; Aritake, N.; Endoh, A. 2010: The efficacy of cetuximab for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2523-2525
Govindarajan, R. 2000: Irinotecan and thalidomide in metastatic colorectal cancer Oncology 14(12 Suppl. 13): 29-32
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481